stoxline Quote Chart Rank Option Currency Glossary
Genenta Science S.p.A. (GNTA)
5.24  0.29 (5.86%)    12-01 09:30
Open: 5.24
High: 5.24
Volume: 1,026
Pre. Close: 4.95
Low: 5.2
Market Cap: 95(M)
Technical analysis
2023-12-01 4:20:16 PM
Short term     
Mid term     
Targets 6-month :  6.42 1-year :  7.5
Resists First :  5.5 Second :  6.42
Pivot price 5.22
Supports First :  4.75 Second :  4.28
MAs MA(5) :  5.13 MA(20) :  5.25
MA(100) :  5.48 MA(250) :  5.81
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  74.2 D(3) :  71.6
RSI RSI(14): 49.2
52-week High :  7.07 Low :  4.28
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ GNTA ] has closed above bottom band by 46.7%. Bollinger Bands are 13.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 5.25 - 5.28 5.28 - 5.3
Low: 5.13 - 5.16 5.16 - 5.19
Close: 5.15 - 5.2 5.2 - 5.25
Company Description

Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company's lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. It is also developing Temferon for use in the treatment of other solid tumor indications, locally advanced hepatocellular carcinoma, and intra-hepatic cholangiocarcinoma. The company was incorporated in 2014 and is headquartered in Milan, Italy.

Headline News

Mon, 09 Oct 2023
ROTH MKM to Host Healthcare Opportunities Conference on ... - GlobeNewswire

Thu, 02 Mar 2023
Sesen Bio stockholders approve 1-for-20 reverse stock split ... - Seeking Alpha

Tue, 17 Jan 2023
Corium Pharma Solutions Appoints Mark Sirgo as Chief Executive ... - Business Wire

Tue, 04 Oct 2022
ROTH Capital Partners to Host Inaugural Healthcare Opportunities ... - GlobeNewswire

Mon, 25 Jul 2022
Bowling Green Bull, un think tank per gli imprenditori che puntano a ... - EconomyUp

Tue, 21 Dec 2021
Genenta si quota al Nasdaq. Il discorso di Pierluigi Paracchi e Luigi ... - StartupItalia

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Shares Out 18 (M)
Shares Float 11 (M)
Held by Insiders 39.4 (%)
Held by Institutions 4.9 (%)
Shares Short 5 (K)
Shares Short P.Month 7 (K)
Stock Financials
EPS -0.78
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 1.36
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -26.4 %
Return on Equity (ttm) -42.5 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -0.76
Qtrly Earnings Growth 0 %
Operating Cash Flow -12 (M)
Levered Free Cash Flow -7 (M)
Stock Valuations
PE Ratio -6.67
PEG Ratio 0
Price to Book value 3.82
Price to Sales 0
Price to Cash Flow -7.63
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android